Articles tagged with Respiratory Disorders
Global neglect of chronic diseases is a pressing issue, with low-cost solutions available for prevention. The authors recommend reframing the debate to emphasize societal determinants and mobilizing resources through cooperative approaches.
Researchers have developed a diagnostic blood test that can identify lymphangioleiomyomatosis (LAM), a rare but serious lung disease affecting women. The test analyzes serum VEGF-D levels, showing high accuracy in diagnosing LAM, and may help screen for the disease in women with Tuberous Sclerosis Complex.
Researchers found that genetic mutations affecting cilia function may predispose older individuals to pulmonary diseases. A simple nitric oxide testing can identify patients at risk of abnormal ciliary function.
Researchers at the University of Pittsburgh School of Medicine have identified a molecular mechanism for idiopathic pulmonary fibrosis (IPF), a chronic and usually lethal disease. The study found that microRNA changes contribute to IPF, with let-7d being significantly reduced in affected tissues.
A new experimental model using pigs with a CF-causing gene mutation has provided valuable insights into the development of lung disease in people with cystic fibrosis. The study's findings suggest that infection precedes inflammation in CF lungs, supporting early and aggressive treatment to delay or prevent lung disease.
Research published in Journal of Thoracic Oncology investigates the effectiveness of surgery as a standalone treatment for stage I small cell lung cancer. The study found three- and five-year survival rates of 58.1% and 50.3%, respectively, for patients who underwent lobectomies without radiotherapy.
A team of scientists led by Dr. Bernard Thébaud has demonstrated that stem cells protect and repair the lungs of newborn rats, boosting the power of healthy lung cells and preventing further damage. This research offers real hope for a new treatment for babies with chronic lung disease.
Researchers at UC San Diego have identified a key protein promoting pulmonary arterial hypertension and developed a drug therapy to block its effects. The treatment, using γ-secretase inhibitor, reversed the disease in mice, offering new hope for patients with this debilitating condition.
A large study found pulmonary NTM disease increasing significantly in men and women in Florida and New York, with no changes in California. The disease is more common among women, particularly in the fifth or sixth decade of life.
A recent study found that cigarette packaging still contains misleading information about health hazards, with consumers incorrectly perceiving certain brands as safer. The researchers advocate for expanded regulations to remove such design elements and promote standardized packaging.
The Pitt team has made significant progress in understanding the molecular mechanisms of disease exacerbation in IPF patients. By analyzing gene activity patterns and protein levels in lung tissue and blood samples, researchers have identified potential biomarkers for predicting patient outcomes and identifying new therapeutic targets.
The NHLBI and UnitedHealth Group collaboration aims to broaden study beyond individual diseases to address chronic diseases as they group. Early results show encouraging progress in developing portable tools and comprehensive guidelines for chronic disease management.
Two recent studies by the University of Cincinnati team found that LAM patients are more likely to participate in clinical trials due to a shared cause and altruism. The research also shows that CT scans given to young women with a collapsed lung can be cost-effective and beneficial in diagnosing the disease.
Researchers found high osteopontin levels in patients with interstitial lung disease and healthy smokers, while healthy non-smokers produced no osteopontin. Osteopontin expression could be stimulated by nicotine treatment, leading to immune cell recruitment and symptoms similar to smoking-related lung diseases.
A new study reveals that two-thirds of the racial gap in death rates among African Americans and Caucasians is due to preventable or treatable conditions. The major contributor to this disparity is conditions with effective treatments, such as stroke, diabetes, and hypertension.
Researchers found that a baseline threshold VO2max of 8.3 ml/kg/min can predict mortality in IPF patients, with those below the threshold having a higher risk of death. The study suggests VO2max as a more robust and clinically usable predictor than other measures.
A major international study highlights the need for improved prenatal care in South-East Asian hospitals to prevent neonatal lung disease. Antenatal corticosteroid treatment before preterm birth has been shown to significantly reduce child death and disease.
The INTEREST study found oral gefitinib comparable to injected docetaxel in non-small cell lung cancer patients, with better quality of life. Common side effects included rash and diarrhoea with gefitinib, while neutropenia and asthenic disorders were more common with docetaxel.
Researchers at the University of Missouri have successfully produced pigs born with cystic fibrosis, mirroring the exact symptoms of humans with the disease. The pigs, carrying only one copy of the mutated gene, are being studied to potentially develop treatments for the fatal lung disease.
Clemson University researcher John R. Saylor has received a $700,000 CDC grant to investigate methods for reducing harmful particulate levels in coal mines. The goal is to lower the incidence of black lung disease and its affiliated ailments by lowering coal-mine dust exposure.
Researchers at University of Cincinnati are studying variations of rare lung disease Lymphangioleiomyomatosis (LAM) to better understand its manifestations and develop more effective treatments. The study will compare patients with and without pulmonary hypertension to identify key differences in symptoms.
Researchers at Johns Hopkins have linked extreme fatigue in lung-scarring disease to poor sleep quality, finding a 25% loss in R.E.M. sleep time among patients. The study shows that people with stiffened lungs and sleep problems experience reduced physical and mental activity scores.
A private foster care program has been shown to significantly improve long-term health outcomes for teenagers placed in the program compared to those in public programs. The study found lower rates of mental disorders, ulcers, and cardiometabolic problems, but more respiratory disorders.
A study found no significant association between exposure to coarse particulate matter and emergency hospital admissions for cardiovascular and respiratory diseases. However, there was a statistically significant association between fine particulate matter and increased risk of illness and death.
A retrospective chart review of 4,000 premature infants found that 50% who received Synagis had lower RSV hospitalization rates than those without the medication. The study's lead author believes physicians' clinical judgment should be relied upon for high-risk patient care.
A Phase 3 study demonstrated that motavizumab reduced hospitalizations due to RSV by 83 percent and lower respiratory infections requiring outpatient management by 71 percent. The study involved 1,410 full-term healthy infants less than six months of age and confirmed high rates of serious RSV disease in this population.
Research highlights diacetyl's acute toxicity and respiratory harm when inhaled by humans. Studies have found that diacetyl can injure lungs, particularly among workers making microwave popcorn and flavoring chemicals.
Palliative care is now considered an integral part of serious respiratory disorders treatment, with individualized and integrated care promoting patient-focused symptom management. The ATS clinical policy statement emphasizes comprehensive care, including professional competence development and education.
Patients with cystic fibrosis who develop life-threatening lung infections pose significant challenges for lung transplantation. The success rate of lung transplants in these patients is lower compared to those without such infections, sparking debate about whether to allocate donor lungs to them.
A study published in Journal of Palliative Medicine explores the concept of hope in ALS patients, revealing a range of coping capabilities that extend beyond physical disability. The research highlights several themes of hope, including personal fulfillment, social support, and spiritual beliefs.
Workers exposed to low levels of an asbestos-like mineral from Montana vermiculite are at increased risk for lung disease today. A 25-year follow-up study found that even low cumulative exposure can cause changes in the lining around the lungs.
Scientists have created a genetically modified pig model that carries the mutated gene responsible for cystic fibrosis, mimicking lung disease in humans. This breakthrough could lead to better understanding of the disease and development of new treatments.
The Kansas State University researchers are analyzing data from feedlots to create decision-making tools for managing bovine respiratory disease complex. They hope to generate estimates of the effect of certain risk factors and develop a system to classify distributions of disease events within feedlot pens.
A recent study found that routine intake of dairy products can lower the instance of gum disease. The American Academy of Periodontology suggests that consuming dairy products like milk, cheese, and yogurt may help achieve a healthy lifestyle, including a healthy mouth.
A new study published in Current Biology confirms the disease threat facing great apes, finding evidence of virus transmission from humans to wild apes. The study also shows that research and tourism projects have suppressed poaching of chimpanzees, outweighing mortality caused by human disease introduction.
A new system has been developed to classify rare lung diseases in infants, improving diagnosis and treatment outcomes. The system groups various lung diseases into distinct categories, allowing pathologists to diagnose children's lung disease more accurately.
Virginia Commonwealth University researchers have discovered a new mechanism to inhibit key enzymes involved in clotting disorders. The newly designed molecules, known as sulfated DHPs, show promise in preventing thrombin and factor Xa's critical action.
MedImmune will present three abstracts at the AAP National Conference & Exhibition, including cost-effectiveness data for palivizumab prophylaxis among preterm infants. The company's surveillance program aims to track RSV activity nationwide and inform improved prevention guidelines.
A Canadian study found that high-dose ibuprofen can slow the decline of lung function in children with mild cystic fibrosis. The treatment reduced hospital stays and improved quality of life for patients.
A study in Great Britain found that even low levels of air pollution boost the chances of an early death, especially from respiratory diseases. The research, which spanned over 16 years, revealed strong links between black smoke and sulphur dioxide with increased risk of mortality.
Survival rates for individuals with scleroderma have increased by 12% over the past 30 years, from 54% to 66%, thanks in part to advancements in treatment. Newer medications such as ACE inhibitors have dramatically improved outcomes for patients, particularly in reducing renal crisis mortality.
A new reovirus has been isolated from bats and can cause a serious but non-fatal respiratory illness in humans. The virus, named Melaka, is closely related to two other bat-borne reoviruses and can be transmitted between people.
Research from Dana-Farber Cancer Institute reveals that Black Americans are less certain about lung cancer prevention recommendations and more fearful of symptoms evaluation, potentially delaying treatment. This fatalism may contribute to Black patients being diagnosed with advanced stages of the disease.
Researchers identify distinct genetic profile associated with rapid progression of IPF, highlighting the need for targeted therapies and closer monitoring. The study's findings may lead to the development of biomarkers for disease progression and more effective treatment strategies.
A subset of patients with idiopathic pulmonary fibrosis (IPF) has been found to have a short duration of symptoms before diagnosis and an accelerated clinical course to end-stage disease. This 'rapid progressor' group is characterized by distinct gene expression patterns, which may lead to the development of new therapeutic interventions.
A Mayo Clinic study found a significant association between rheumatoid arthritis and chronic lung diseases, with cumulative incidence rates increasing over time. The study followed 603 patients with RA for up to 30 years, revealing higher rates of obstructive lung disease and diffuse parenchymal infiltrative lung disease.
Researchers have identified unique expression domains for two proteins, SPLUNC1 and SPLUNC2, in the lungs of people with cystic fibrosis. The discovery could help understand the immune system's role in the disease and potentially prevent lung damage.
A study of 4,181 adults found anxiety disorders independently associated with several physical conditions, increasing disability risk. Anxiety disorders were also linked to poorer quality of life in individuals with both conditions.
A randomized clinical trial has proven that a drug can slow down deterioration of lung function in scleroderma patients. Participants who received treatment had a small but statistically significant improvement in lung function and less shortness of breath compared to those who were not treated.
Research highlights the threat of biological diversity loss to human health, citing Lyme disease and West Nile virus as examples. A rapid autopsy program for a rare lung disease called interstitial pulmonary fibrosis (IPF) also improves medical research outcomes.
The National Institutes of Health (NIH) has launched a $71 million effort to investigate rare diseases affecting fewer than 200,000 persons in the US. The Clinical Research Consortium Network (RDCRN) aims to develop personalized treatments and prevent complications through genetic research.
The Broad Institute scientists will survey DNA of 50,000 individuals using large-scale genotyping technologies and advanced informatics to highlight genetic differences in specific genes. The project aims to accelerate the pace of identifying risk factors and genetic variants associated with human diseases.
Researchers have identified novel drug therapies, including endothelin antagonists and prostacyclin, that improve quality and quantity of life for patients with PAH. These treatments offer hope for patients who previously faced lung transplantation.
A study found that elevated BNP levels are associated with increased mortality and significant pulmonary hypertension in patients with chronic lung disease. Pulmonary artery pressure above 35 mmHg is a key indicator of this condition.
Fine particulate matter exposure (PM2.5) was associated with short-term increases in hospital admission rates for all health outcomes except injuries. Cardiovascular risks were highest in Eastern US counties, with a 1.28% increase in heart failure risk per 10-µg/m3 PM2.5.
A 14-year study published in Annals of Internal Medicine found that quitting smoking can add years to life. The study showed a significant reduction in death rates among participants who quit compared to those who continued to smoke.
Researchers identify specific T cells and staining methods that improve detection and treatment of RA lung disease. The study suggests therapies targeting T cell function may succeed in treating RA lung disease, while early detection could lead to prolonged lives for patients.
A study of 2500 babies found no difference in outcomes between those who received suctioning and those who did not, challenging current guidelines on perinatal treatment. The results suggest that routine suctioning may not be effective in preventing meconium aspiration syndrome (MAS) or its complications.
Researchers have identified six essential genes for cilia formation in humans, which could help diagnose and treat diseases such as infertility, pulmonary diseases, and vision problems. The discovery provides a critical new tool for medical researchers to understand the genetic basis of these disorders.
New studies release at the American Urological Association (AUA) show Enablex significantly reducing overactive bladder symptoms, including incontinence episodes and nocturia. Enablex improved efficacy parameters associated with OAB without CNS or CV safety concerns.